GLP-1s are shown to be effective for weight loss, but tracking muscle-mass retention has remained a missing piece — until now, Noom’s CEO says
Noom is adding in-app body scan technology that will help GLP-1 users measure important body composition metrics, track progress, and monitor possible muscle mass loss.
The digital healthcare company partnered with AI and machine learning company Prism Labs to provide the new body scan technology, which uses a smartphone camera.
“GLP-1s are highly effective in driving weight loss, however, much of the weight lost is actually muscle mass,” Noom CEO Geoff Cook said. Last year, Cook was named Noom’s CEO as the platform began its push into the weight loss medication space.
“Our partnership with Prism Labs makes accurate body mapping available to everyone,” Cook continued. “Our Muscle Defense fitness program emphasizes resistance training, and our thousands of high-protein recipes encourage healthy eating, but we needed a simple and accurate way to monitor muscle-mass retention. Now we have it. Now everyone on Noom can gain the body intelligence to live better longer.”
Members record a 10-second body scan video with the Noom app. The AI then analyzes the video, determines precise body composition measurements, and creates a personalized 3D body avatar. Machine-learning software then calculates the user’s body composition and metrics such as body fat percentage, fat mass, waist-to-hip ratio, and lean mass. The data is used to create a comprehensive health report and visualization.
The new body scan and health report feature will become available to all Noom Healthy Weight and Noom Med subscribers in the coming weeks.
“Noom is an ideal partner because of their focus on using the best technology to empower everyone, everywhere, to live better longer,” Prism Labs CEO Steve Raymond said. “We built our platform to provide anyone with a smartphone with precise, accurate body composition information and health insights that were previously only available using expensive hardware. We’re thrilled to help Noom personalize their programming and empower and motivate their users to take control of their health while making our technology accessible to many millions of people.”
Noom’s New Enterprise Weight Loss Products
Noom has also launched two new pathways for employers to provide their team members with weight loss medications: Noom Med with Smart Rx, a partnership with Waltz Health and Noom Weight with GLP-1 Rx.
Noom Med with Smart Rx offers direct and cost-effective access to GLP-1 medications, where employers can cover the drugs as a supplemental benefit. Noom Weight with GLP-1 Rx, on the other hand, gives employers the option to offer weight loss support in the form of Noom’s behavior change program with the option to receive a discount on non-branded GLP-1 medications, such as the digital healthcare company’s compounded semaglutide product.
Both products will be available to employers in January 2025.
